Optimization of a Photoretinoscopy Method for Determining the Objective Refraction of Children With a Smartphone/add-on Device in India
NCT ID: NCT06524115
Last Updated: 2025-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
122 participants
INTERVENTIONAL
2024-10-03
2024-12-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimization of a Photoretinoscopy Method for Determining the Objective Refraction of Children
NCT06295536
Performance of Refractometers With Self-adjusting Lenses Compared to Cycloplegia in Children (REFRALENS)
NCT06668246
Effect of Orthokeratology Versus Spectacles on Myopia Progression in Chinese Children: A Crossover Trial
NCT02186184
Peripheral Optics in Myopia and Orthokeratology
NCT00978679
Light Diffraction Glasses in Preventing and Controlling Myopia in Adolescents
NCT06927414
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Photorefraction prototype device
\- Photoretinoscopic images without cycloplegia
Comparator device, Closed-field autorefractometer without cycloplegia
Objective refraction without cycloplegia
Distance visual acuity check using objective refraction without cycloplegia
Distance visual acuity is checked, using objective refraction without cycloplegia
Comparator device, Closed-field autorefractometer with cycloplegia
Objective refraction with cycloplegia
Distance visual acuity check using objective refraction with cycloplegia
Distance visual acuity is checked, using objective refraction with cycloplegia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Comparator device, Closed-field autorefractometer without cycloplegia
Objective refraction without cycloplegia
Distance visual acuity check using objective refraction without cycloplegia
Distance visual acuity is checked, using objective refraction without cycloplegia
Comparator device, Closed-field autorefractometer with cycloplegia
Objective refraction with cycloplegia
Distance visual acuity check using objective refraction with cycloplegia
Distance visual acuity is checked, using objective refraction with cycloplegia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 6 years old and up to 12 years old at time of informed consent and assent
* Average of the equivalent sphere(Sph+Cyl/2) of both eye included in the interval \[-10.00, +8.00\]
* Cylindrical refractive error between 0 and 4.00 D on both eyes
* Corrected binocular visual acuity in distance vision at least 6/9
Exclusion Criteria
* All categories of persons particularly protected by law
* Subject in another study which might have an influence on vision or interfere with study assessment
* Less than 6 years old, or 13 years old or above at time of informed consent and assent
* Amblyopia, Cataract, Strabismus.
* Aphakic or pseudophakic (intraocular implant)
* Reported severe eye disease involving loss of visual field as in glaucoma, involving loss of acuity and severe discomfort in low or overly bright environments as in retinitis pigmentosa or reported and treated dry eye.
* Self-reported neurological deficits, including a history of epileptic pathology or sensory-motor coordination disorders, vestibular or cerebellar pathology (e.g., balance disorders, nystagmus)
* Any previous ocular surgery, which might have an influence on vision or interfere with study assessments (e.g. iridectomy, refractive surgery…),
* Any myopia control solutions that could affect refractive status of the eye (e.g. Atropine eye drops, Orthokeratology)
6 Years
13 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Essilor International
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Krishna Kumar
Role: PRINCIPAL_INVESTIGATOR
Sankara Nethralaya, Unit of Medical Research Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sankara Nethralaya, Unit of Medical Research Foundation
Chennai, Tamil Nadu, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WS10364
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.